Navigation Links
Innovotech signs agreement for distribution of its bioFILM PA test in Israel
Date:8/12/2010

Edmonton, Alberta, July 27, 2010 Innovotech Inc. (TSX-V: IOT), a pioneer in the field of biofilm product development, has signed an exclusive distribution agreement with LevPharm Ltd of Israel to market and distribute its bioFILM PA test to hospitals and clinics within Israel.

"We are very excited to enter into this agreement with LevPharm, who recognize the significant impact the bioFILM PA test can have on improving patient care while reducing the cost burden to health care systems," said Ken Boutilier, President and CEO of Innovotech Inc. "The partnership with LevPharm illustrates their understanding of the importance of technologies for biofilm management, and further demonstrates Israel's leadership in embracing innovative products and solutions to enhance their health care system."

The current market capacity in Israel for acute infection treatment alone is estimated to be over 3,000 bioFILM PA tests per year.

bioFILM PA is the first diagnostic test to assist physicians in the selection of the most effective combination antibiotic treatment of patients with biofilm-based Pseudomonas aeruginosa infections.

Pseudomonas aeruginosa is a common bacterium responsible for many hospital acquired infections including ventilator-associated pneumonia and those found in patients with burns and wounds. It is also one of the major causes of lung infections in individuals with Cystic Fibrosis.

Over eighty percent of microbial infections in the body are caused by organisms in a biofilm state. Biofilm infections are known to be up to 4,000 times more resistant to antibiotics than the same organism in a free-floating state, which demonstrates why it is so critical to identify effective treatments early, such as through the bioFILM PA test.


'/>"/>

Contact: Ken Boutilier
ken.boutilier@innovotech.ca
780-448-0585
Innovotech Inc.
Source:Eurekalert

Page: 1

Related biology news :

1. Innovotech receives funding to advance environmentally friendly agricultural crop protection product
2. Syngenta Crop Protection Canada announces seed treatment project with Innovotech
3. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
4. Signs of reversal of Arctic cooling in some areas
5. Lake sturgeon have genes from parasite, signs of human STD
6. Phosphorous in sodas and processed foods accelerates signs of aging say Harvard scientists
7. Moffitt Cancer Center signs licensing agreement with Proteacel, LLC
8. Springer signs publishing agreement with ISOBM
9. Springer signs agreement with British Society of Research on Ageing
10. Copying mother natures designs
11. Plate-eating good: Université de Montréal professor designs edible tableware
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
(Date:12/16/2016)... 16, 2016 The global wearable medical device market, in ... 2021 from USD 5.31 billion in 2016, at a CAGR of ... ... technological advancements in medical devices, launch of a growing number of ... connectivity among healthcare providers, and increasing focus on physical fitness. ...
(Date:12/15/2016)... 2016 Advancements in biometrics will ... and wellbeing (HWW), and security of vehicles ... passenger vehicles begin to feature fingerprint recognition, ... beat monitoring, brain wave monitoring, stress detection, ... pulse detection. These will be driven by ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... formation of its Medical/Clinical Advisory Board.  This new ... who enhance the range and depth of expertise ... its novel prenatal diagnostic tests.  These experts are ... guidance for the company,s product development and commercialization ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the "Implantable Biomaterials ... report to their offering. Report Highlights: ... detailed analysis on current and future market trends to identify the investment ... as the base numbers Key market trends across the ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research ... leading biopharmaceutical and medical device manufacturers and regulators, is proud to announce the ... 11-compliant email client designed to provide product vigilance departments with the flexibility and ...
(Date:1/19/2017)... 19, 2017  ArmaGen, Inc., today announced that ... as chief executive officer, as well as a ... to ArmaGen more than 17 years of executive ... of biotherapeutics and pharmaceuticals. "Mathias ... experience and skillset necessary to lead ArmaGen to ...
Breaking Biology Technology: